SCM
ARTV

Sterling Capital Management’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Sterling Capital Management’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-158
Closed -$474 – 3429
2025
Q1 		$474 Sell
158
-58
-27% -$174 ﹤0.01% 2964
2024
Q4 		$2.18K Buy
216
+185
+597% +$1.87K ﹤0.01% 2764
2024
Q3 		$479 Buy
+31
New +$479 ﹤0.01% 2891